15th April 2019

iGrants Funding

Tenovus Cancer Care is committed to funding research which directly helps people affected by cancer in communities across Wales. Through our iGrant funding stream, we fund research that highlights or meets the needs of cancer patients and their families, including cancer prevention research.

Our iGrants represent innovation, projects that implement great ideas, involve patients and public, influence policy and practice, and invest in the future.

In our previous round, we funded six projects at a cost of £134,240. This was a success rate of 40% based on the initial call of expressions of interest. To see some examples of our currently funded iGrants, click here.

Current funding opportunities


Eligibility and Guidance

The Tenovus Cancer Care iGrants are open to all, including individuals, patient groups, academic institutions, health professionals and voluntary organisations, where the lead applicant is based in Wales. Co-applicants or collaborators may be from outside of Wales. We welcome applications for projects of all sizes from £1,000 up to a maximum of £30,000 for up to 24 months.

Projects must meet the vision and mission of Tenovus Cancer Care. Projects must have a research element; there must be a research question or uncertainty being investigated. Proposals must also demonstrate an impact on cancer patients and their families, or have the potential to do so in the future.

New for 2019 – Living with and Beyond Cancer

NCRI Logo 1

Tenovus Cancer Care is a member of the National Cancer Research Institute and has been involved in a project with the James Lind Alliance to determine priorities for research that will help people live better with and beyond cancer. This 2 year project involved two UK-wide surveys which attracted more than 3,500 responses from patients, carers, and health and social care professionals. From these, they identified 26 key questions and distilled these down to 10 top research priorities.

Although this is not a requirement to be eligible for iGrant funding, Tenovus Cancer Care will look favourably upon applications that address one of the top 10 priorities.

Please download our Expression of Interest guidance document for more information.

How to apply

The iGrant application process consists of two stages – the Expression of Interest (EoI) stage and the full application stage. All applicants must complete the EoI form. This application will be reviewed by our Research Advisory Group.

Please send your completed Expression of Interest to by Tuesday 23rd April.

Successful applicants will then be invited to submit a full application via email.

Download the documents

Paperclip Orangeweb2

iGrants Guidance Document

Paperclip Orangeweb2

iGrants Expression of Interest Form

For more information, advice, or if you are unsure of your eligibility, please contact Jess Hall, Research Grants Officer on or call 029 2076 8787.

If you would like to sign up to receive our funding call list and be notified when the next round is open please complete the form here.